Apoptosis triggered redistribution of caspase-9 from cytoplasm to mitochondria

FEBS Lett. 2003 Jun 5;544(1-3):153-9. doi: 10.1016/s0014-5793(03)00494-0.

Abstract

Caspase-9 is an apoptosis initiator protease activated as a response to the mitochondrial damage in the cytoplasmic complex apoptosome. By fluorescence labelling of proteins, confocal microscopy and subcellular fractionations we demonstrate that caspase-9 is in the cytoplasm of non-apoptotic pituitary cells. The activation of apoptosis with rotenone triggers the redistribution of caspase-9 to mitochondria. Experiments using the general caspase inhibitor z-VAD.fmk and the specific caspase-9 inhibitor z-LEHD.fmk show that the caspase-9 redistribution is a regulated process and requires the activity of a caspase other than the caspase-9. We propose that this spatial regulation is required to control the activity of caspase-9.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology
  • Apoptosis*
  • Caspase 9
  • Caspases / biosynthesis*
  • Caspases / metabolism
  • Cytoplasm / metabolism*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Immunohistochemistry
  • Microscopy, Confocal
  • Microscopy, Fluorescence
  • Mitochondria / metabolism*
  • Recombinant Fusion Proteins / metabolism
  • Rotenone / pharmacology
  • Subcellular Fractions
  • Transfection

Substances

  • Amino Acid Chloromethyl Ketones
  • Enzyme Inhibitors
  • Recombinant Fusion Proteins
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Rotenone
  • CASP9 protein, human
  • Caspase 9
  • Caspases